Today in our 2nd Industry Education Session at
#ASHG25, Sheila Dodge, Chief Operating Officer - Broad Clinical Labs, presented hot off the press early access data from a PerturbSeq experiment comprising >5 million cells processed in just 5 days, plug-and-play in their first attempt. Illumina Single Cell technology removes limitations in single cell analysis—scaling from 100s to 1M cells in one tube. (8/9)